Cited by 115Cystic Fibrosis Research AdvancesInhalation and Respiratory Drug DeliveryBacterial biofilms and quorum sensing

Gaseous nitric oxide to treat antibiotic resistant bacterial and fungal lung infections in patients with cystic fibrosis: a phase I clinical study

Deppisch, Caroline, Herrmann, Gloria, Graepler-Mainka, Ute, Wirtz, Hubertus, Heyder, Susanne, Engel, Corinna, Marschal, Matthias, Miller, Christopher C. +1 more·2016·Infection

Abstract

Background Individuals with cystic fibrosis (CF) receive antibiotics continuously throughout their entire life which leads to drug resistant microbial lung infections which are difficult to treat. Nitric oxide (NO) gas possesses antimicrobial activity against a wide variety of microorganisms in vitro, in vivo in animal models and a phase I study in healthy adults showed administration of intermittent 160 ppm NO to be safe. Methods We assessed feasibility and safety of inhaled NO in eight CF patients who received 160 ppm NO for 30 min, three times daily for 2 periods of 5 days. Results The NO treatment was safe and in none of the patients were serious drug-related adverse events observed which caused termination of the study. The intention-to-treat analysis revealed a significant mean reduction of the colony forming units of all bacteria and all fungi, while mean forced expiratory volume 1 s % predicted (FEV1) relative to baseline increased 17.3 ± 8.9 % (P = 0.012). Conclusions NO treatment may improve the therapy of chronic microbial lung infections in CF patients, particularly concerning pathogens with intrinsic or acquired resistance to antibiotics.

Integrity signals

Registry

Crossref · 10.1007/s15010-016-0879-x

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Deppisch, C., Herrmann, G., Graepler-Mainka, U., Wirtz, H., Heyder, S., Engel, C., Marschal, M., Miller, C. C., & Riethmüller, J.
Affiliations
  • University Children's Hospital Tübingen (DE)
  • University Hospital Leipzig (DE)
  • Robert Bosch Hospital (DE)
  • Universitätsklinikum Tübingen (DE)
  • University of British Columbia (CA)
Corresponding author
Riethmüller, Joachim
Venue
Infection
Published
2016-02-09
Volume
44
Issue
4
Pages
513-520
ISSN
  • 0300-8126 (ISSN-L)
  • 1439-0973
OpenAlex
W2254558178
Cited by
115
References
34
Citations by year
2026: 7 · 2025: 9 · 2024: 6 · 2023: 20 · 2022: 10 · 2021: 15 · 2020: 20 · 2019: 13 · 2018: 8 · 2017: 7
FWCI
8.35
Type
journal article
Language
en
Open access
closed
Locations
  • Infection (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Real-Fund, Linde AG, Munich, Germany
  • Förderverein Mukoviszidose eV Neckar Alb, Dettingen
  • Mukoviszidose eV Baden-Württemberg, Germany
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
Keywords
nitric oxide, inhaled nitric oxide, cystic fibrosis, antibiotic resistance, bacterial lung infection, fungal lung infection, antimicrobial activity, treatment safety, forced expiratory volume, chronic lung infection
MeSH terms
Adult, Anti-Infective Agents, Cystic Fibrosis, Feasibility Studies, Female, Forced Expiratory Volume, Humans, Male, Nitric Oxide, Respiratory Tract Infections, Drug Resistance, Bacterial, Drug Resistance, Fungal

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review